Transcat, Inc. (NASDAQ:TRNS) Shares Sold by Jane Street Group LLC

Jane Street Group LLC lowered its position in Transcat, Inc. (NASDAQ:TRNS - Free Report) by 41.0% in the 3rd quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 7,251 shares of the scientific and technical instruments company's stock after selling 5,037 shares during the period. Jane Street Group LLC owned 0.08% of Transcat worth $876,000 as of its most recent SEC filing.

Several other hedge funds also recently made changes to their positions in TRNS. Conestoga Capital Advisors LLC raised its position in shares of Transcat by 17.9% in the 3rd quarter. Conestoga Capital Advisors LLC now owns 907,191 shares of the scientific and technical instruments company's stock worth $109,561,000 after purchasing an additional 137,830 shares during the last quarter. Millrace Asset Group Inc. bought a new position in shares of Transcat in the third quarter worth approximately $655,000. Champlain Investment Partners LLC grew its holdings in shares of Transcat by 22.1% during the third quarter. Champlain Investment Partners LLC now owns 409,500 shares of the scientific and technical instruments company's stock valued at $49,455,000 after buying an additional 74,169 shares during the last quarter. State Street Corp increased its position in shares of Transcat by 8.1% during the third quarter. State Street Corp now owns 207,230 shares of the scientific and technical instruments company's stock valued at $25,027,000 after acquiring an additional 15,514 shares in the last quarter. Finally, BNP Paribas Financial Markets increased its position in shares of Transcat by 64.0% during the third quarter. BNP Paribas Financial Markets now owns 22,661 shares of the scientific and technical instruments company's stock valued at $2,737,000 after acquiring an additional 8,844 shares in the last quarter. 98.34% of the stock is currently owned by institutional investors.

Transcat Trading Up 0.3 %

Shares of NASDAQ:TRNS traded up $0.33 during trading on Thursday, reaching $106.07. The stock had a trading volume of 65,190 shares, compared to its average volume of 54,912. The company has a market capitalization of $975.74 million, a P/E ratio of 53.57 and a beta of 0.70. The firm's 50-day simple moving average is $105.95 and its 200 day simple moving average is $117.54. Transcat, Inc. has a one year low of $94.29 and a one year high of $147.12.

Transcat (NASDAQ:TRNS - Get Free Report) last released its quarterly earnings results on Monday, October 28th. The scientific and technical instruments company reported $0.35 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.47 by ($0.12). Transcat had a return on equity of 7.36% and a net margin of 6.63%. The firm had revenue of $67.83 million during the quarter, compared to analysts' expectations of $70.30 million. During the same period in the prior year, the firm posted $0.41 earnings per share. Transcat's revenue for the quarter was up 8.0% compared to the same quarter last year. Equities research analysts forecast that Transcat, Inc. will post 1.76 earnings per share for the current fiscal year.

Analyst Ratings Changes

Several equities research analysts recently issued reports on TRNS shares. Craig Hallum raised their target price on shares of Transcat from $113.00 to $125.00 and gave the stock a "buy" rating in a report on Thursday, December 12th. HC Wainwright reissued a "buy" rating and issued a $156.00 price objective on shares of Transcat in a research note on Tuesday, October 29th. StockNews.com downgraded Transcat from a "hold" rating to a "sell" rating in a research note on Tuesday, October 29th. Oppenheimer reissued an "outperform" rating and set a $130.00 price objective (down previously from $155.00) on shares of Transcat in a report on Wednesday, October 30th. Finally, Northland Securities reduced their price target on shares of Transcat from $130.00 to $110.00 and set a "market perform" rating on the stock in a research report on Wednesday, October 30th. One investment analyst has rated the stock with a sell rating, two have given a hold rating and three have issued a buy rating to the company. According to data from MarketBeat.com, the stock has an average rating of "Hold" and a consensus price target of $130.25.

Transcat Profile

Transcat, Inc provides calibration and laboratory instrument services in the United States, Canada, and internationally. It operates through two segments: Service and Distribution. The Service segment offers calibration, repair, inspection, analytical qualification, preventative maintenance, consulting, and other related services.